MANITOBA
TAKHZYRO is reimbursed in Manitoba with restrictions as a Part 3 Exception Drug Status (EDS) benefit under the EDS Program. The complete criteria may be obtained from the EDS office at Manitoba Health.
OnePath® can assist in determining eligibility once the patient is enrolled in the OnePath® program.
